Drug-Eluting Stents Market Analysis, By Service, Size, Share, Growth, Segment, Trends and Forecast 2023-2028

According to the latest report by IMARC Group, titled “Drug-Eluting Stents Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” the global drug-eluting stents market size reached US$ 7.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 11.4 Billion by 2028, exhibiting a growth rate (CAGR) of 6.31% during 2023-2028.

Drug-eluting stents refer to coronary or peripheral tools that are widely used in the treatment of blockage of heart arteries. These stents are generally placed within the coronary or peripheral artery by an interventional radiologist or cardiologist during an angioplasty procedure. They are small mesh tubes that are generally manufactured using metal or polymers and coated with slow-release medication that is inserted into an artery for preventing the formation of scar tissues in arterial walls. As a result, they ensure adequate blood flow to the body while minimizing the chance of restenosis.

Request for a PDF Sample of this Report: https://www.imarcgroup.com/drug-eluting-stents-market/requestsample

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Global Drug-Eluting Stents Market Trends:

The global market is primarily driven by the rising prevalence of coronary heart diseases among the masses. This is supported by the sedentary lifestyle patterns and unhealthy dietary habits of individuals. Since drug-eluting stents are minimally invasive in nature, facilitate fast vessel healing and reduce the need for prolonged dual antiplatelet therapy, this is providing a boost to the market growth. Additionally, continual product innovations, such as the utilization of antiproliferative drugs in the stent in order to reduce the chance of in-stent restenosis, are gaining widespread prominence. In line with this, the introduction of drug-eluting stents manufactured using bioabsorbable polymers due to an enhanced focus on sustainable development is creating a positive outlook for the market. Moreover, increasing investments by private and public agencies in upgrading the existing healthcare infrastructure are also propelling the market growth. Other factors, including the rising geriatric population, the growing healthcare expenditure, and extensive research and development (R&D) activities conducted by key players, are further contributing to the market growth.

Drug-Eluting Stents Market 2023-2028 Competitive Analysis and Segmentation:

Competitive Landscape With Key Players:

The competitive landscape of the drug-eluting stents market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

  • Abbott Laboratories
  • Braun Melsungen AG
  • Biosensors International Group Ltd
  • Biotronik
  • Boston Scientific Corporation
  • Cardinal Health Inc
  • Cook Medical LLC (Cook Group Incorporated)
  • Lepu Medical Technology (Beijing) Co. Ltd
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Sino Medical Sciences Technology Inc
  • Terumo Corporation

Key Market Segmentation:

Breakup by Coating: 

  • Polymer Based Coating
  • Polymer Free Coating

Breakup by Drug:

  • Sirolimus
  • Paclitaxel
  • Zotarolimus
  • Everolimus
  • Biolimus
  • Others

Breakup by Stent Platform:

  • Stainless-steel
  • Cobalt-Chromium
  • Platinum-Chromium
  • Nitinol
  • Others

Breakup by Generation:

  • 1st Generation
  • 2nd Generation
  • 3rd Generation
  • 4th Generation

Breakup by Application:

  • Coronary Artery Disease
  • Peripheral Artery Disease

Breakup by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Breakup by Region:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)

Ask Analyst for Customization and Explore full Report with TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=4815&flag=E

Key Highlights of the Report:                                                           

  • Market Performance (2017-2022)
  • Market Outlook (2023-2028)
  • Market Trends
  • Market Drivers and Success Factors
  • Impact of COVID-19
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Media Contact:
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: sales@imarcgroup.com
Phone: +1-631-791-1145
Address: 30 N Gould St Ste R
City: Sheridan
State: WY
Country: United States

 

 

Comments

Post a Comment

Popular posts from this blog

Outsourcing in Banking: Enhancing Efficiency and Addressing Risks

Image
Outsourcing in the banking sector has become a crucial strategy for streamlining products and services, optimizing resource management, reducing costs, and ultimately delivering greater value to customers. As financial institutions navigate a complex regulatory landscape, they are increasingly focusing on their core activities and looking for ways to enhance operational efficiency. The Need for Cost Optimization Banks face various challenges, including capital requirements, financial reporting, and corporate governance standards. Many institutions have shifted their attention from global capital markets to concentrate on their fundamental banking operations. This shift is essential not only for compliance but also for maintaining competitiveness in a market where operating costs significantly impact the pricing of financial products. To remain competitive, banks must find ways to lower their operational costs without compromising service quality. This is where outsourcing comes into pl...
Read more

North America Frozen Seafood Market: Industry Overview, Growth, Trends, Opportunities and Forecast Till 2026

Image
 According to IMARC Group’s latest report, titled “ North America Frozen Seafood Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026 ”, the North America frozen seafood market reached a value of US$ 13.4 Billion in 2020. Frozen seafood products are preserved for inhibiting the growth of bacteria in order to increase their shelf life, taste, and nutritional value. The seafood freezing technique includes two different approaches, namely, cryofreezing and carboxymethylcellulose. In cryofreezing, seafood items, such as salmon, tuna, shrimp, oysters, and tilapia, are kept in ultra-low liquid nitrogen for maintaining their quality. On the other hand, carboxymethylcellulose is used to curb the adulteration of seafood commodities. We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report. Request for a PDF sample of this report : https...
Read more

Biosimilar Market Size 2022-27: Trends, Share, Growth, Opportunity and Forecast

Image
According to the recent report by IMARC Group, entitled “ Biosimilar Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027 ”, the  global biosimilar market size was estimated to be US$ 13.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 60.8 Billion by 2027, exhibiting at a CAGR of 26.1% during 2022-2027. Biosimilars, also known as subsequent entry biologics (SEBs) or follow-on biologics, refer to FDA-approved biotherapeutic products which are similar to their reference biologics. Biosimilars can only be manufactured after the patent of the reference product expires. The demand for biosimilars has been increasing in recent years as they help in reducing the overall cost of the treatment for a variety of chronic diseases including cancers, autoimmune diseases, kidney failure, diabetes, CVDs, haematological disorders, infectious diseases, rheumatoid arthritis, growth hormone deficiency, etc. We are regularly track...
Read more